David Poutney, CEO of Dowgate Capital, is supporting Belluscura’s Crowdfunding initiative

BelluscuraNews

“Belluscura’s patented technology in the medical oxygen space has huge commercial potential whilst at the same time providing significant benefits to the lives of those suffering from COPD. I lost a dear friend to this debilitating disease and X-PLOR would have made a tremendous difference to quality of life in his final years. With other important applications in other fields such as wound care and portable artificial lungs, Belluscura can become a major player in the medical technology arena.”

Take advantage of this healthcare investment opportunity!    

Investment Notice: Neither Belluscura or Crowdcube is soliciting investors in the United States, Canada or Japan or any other country where it would be unlawful for its pitches to be advertised. Investors must not register or view pitches if they are resident in these countries.